IOBT: IO Biotech Inc. Cash Calculated per Single Share

IO Biotech Inc. - graphic logo of issuer IOBT

IO Biotech, Inc. (IOBT) dynamics depend on the results of the IO102-IO103 vaccine trials and the attention of pharma behemoths. The change in cash per share visualizes this trend, where 0.00 shows the current volume of the metric. Liquidity relies on grants and oncology partnerships, while development efficiency is enhanced through cloud-based genome analysis and laboratory robotics.

IO Biotech, Inc. (IOBT) - Cash per Share from 07/04/2022 to 04/18/2026

Comprehensive metric breakdowns and analytics for iobiotech.com (IOBT)

- current quotes and average value forecast:
- market capitalization information:
- cash availability and cash flow indicators:
Comprehensive company analysis:IO Biotech, Inc. (IOBT)
Flagship merchandise of IO Biotech, Inc.

This indicator determines the volume of liquid assets per common share, separating the fundamental value of capital from market volatility and assessing the asset's intrinsic stability. For IO Biotech, Inc. (IOBT), which finances costly clinical trials for cancer vaccines, the cash per share level serves as a key measure of the business's "margin of safety" until the drugs reach commercialization.